Eli Lilly said sales of weight reduction drug Zepbound and diabetes treatment Mounjaro surged in the very first quarter.
Source
Related Articles
Eli Lilly sales skyrocket 45% on weight loss drug demand, but drugmaker cuts earnings outlook after cancer treatment deal